162774-06-3
162774-06-3
Chemical Structure
Nerelimomab
Synonym(s): BAYX1351
- CAS No.: 162774-06-3
- Formula:N/A
- Molecular Weight:N/A
IUPAC Name: (S)-N-(2-(4-(tert-butyl)-1-phenyl-4,5-dihydro-1H-imidazol-2-yl)phenyl)-2-methylquinolin-8-amine
SMILES: [Nerelimomab]
Biological Activity: Nerelimomab (BAYX1351) is an anti-TNF-α antibody. Nerelimomab can be used for research of sepsis[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Nerelimomab | Nerelimomab (BAYX1351) is an anti-TNF-α antibody. Nerelimomab can be used for research of sepsis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Schlag G, et al. Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Shock. 1994 Jul;2(1):10-8; discussion 19-22. [Content Brief]
- [2]. Cohen J, et al. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med. 1996 Sep;24(9):1431-40. [Content Brief]
Keywords
